936-05-0
936-05-0
Chemical Structure
HMMNI
Synonym(s): Hydroxy Dimetridazole
- CAS No.: 936-05-0
- Formula:C5H7N3O3
- Molecular Weight:157.13
IUPAC Name: (1-methyl-5-nitro-1H-imidazol-2-yl)methanol
InChIKey: JSAQDPJIVQMBAY-UHFFFAOYSA-N
SMILES: OCC1=NC=C([N+]([O-])=O)N1C
Biological Activity: HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazole (HY-B1244). Dimetridazole is a nitroimidazole class drug that combats protozoan infections[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HMMNI | 99.91% | HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazole (HY-B1244). Dimetridazole is a nitroimidazole class drug that combats protozoan infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HMMNI (Standard) | ≥98% | HMMNI (Standard) (Hydroxy Dimetridazole (Standard)) is the analytical standard of HMMNI (HY-W008216). This product is intended for research and analytical applications. HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazol (HY-B1244). Dimetridazole is a nitroimidazole class drug that combats protozoan infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HMMNI-d3 | 99.90% | HMMNI-d3 (Hydroxy Dimetridazole-d3) is deuterium labeled HMMNI (HY-W008216). HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazol (HY-B1244). Dimetridazole is a nitroimidazole class agent that combats protozoan infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Cronly M, et al. Rapid confirmatory method for the determination of 11 nitroimidazoles in egg using liquid chromatography tandem mass spectrometry. J Chromatogr A. 2009;1216(46):8101‐8109. [Content Brief]
- [2]. Walsh JS, et al., Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles. J Med Chem. 1987 Jan;30(1):150-6. [Content Brief]
Keywords
